Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel H Greig

Showing results (281-290 of 332) with videos related to

Pageof 34
Sort By:
Glia|July 4, 2023
Microglial Nogo delays recovery following traumatic brain injury in miceElliot J Glotfelty, Shih-Chang Hsueh, Quia Claybourne, et al.
Plos One|July 19, 2011
Extension of lifespan in C. elegans by naphthoquinones that act through stress hormesis mechanismsPiper R Hunt, Tae Gen Son, Mark A Wilson, et al.
International Journal of Molecular Sciences|March 11, 2023
PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's DiseaseTung-Tai Kuo, Yuan-Hao Chen, Vicki Wang, et al.
International Journal of Pharmaceutics|August 6, 2022
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodentMaria Cristina Cardia, Maria Francesca Palmas, Luca Casula, et al.
Journal of Neuroscience Research|January 24, 2007
Apoptotic and behavioral sequelae of mild brain trauma in miceDavid Tweedie, Anat Milman, Harold W Holloway, et al.
Biochemical and Biophysical Research Communications|August 3, 2025
Monoterpenoid fluorophthalimide IMiDs that lack human cereblon binding: synthesis and anti-proliferative, anti-angiogenic and anti-inflammatory activitiesWeiming Luo, Kathleen M Garchitorena, David Tweedie, et al.
International Journal of Nanomedicine|November 27, 2025
Enhanced Bioavailability of a Thionated IMiD Derivative Nanosuspension for Parkinson's Disease Targeting α-SynucleinLuca Casula, Maria Francesca Palmas, Maria Cristina Cardia, et al.
Pharmacogenetics and Genomics|March 13, 2008
Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's diseaseRoger Lane, Howard H Feldman, Joanne Meyer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 18, 2014
Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryNigel H Greig, David Tweedie, Lital Rachmany, et al.
Scientific Reports|June 18, 2017
Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degenerationLital Rachmany, David Tweedie, Vardit Rubovitch, et al.
Pageof 34

Showing results (281-290 of 332) with videos related to

Sort By:
Pageof 34
Glia|July 4, 2023
Microglial Nogo delays recovery following traumatic brain injury in miceElliot J Glotfelty, Shih-Chang Hsueh, Quia Claybourne, et al.
Plos One|July 19, 2011
Extension of lifespan in C. elegans by naphthoquinones that act through stress hormesis mechanismsPiper R Hunt, Tae Gen Son, Mark A Wilson, et al.
International Journal of Molecular Sciences|March 11, 2023
PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's DiseaseTung-Tai Kuo, Yuan-Hao Chen, Vicki Wang, et al.
International Journal of Pharmaceutics|August 6, 2022
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodentMaria Cristina Cardia, Maria Francesca Palmas, Luca Casula, et al.
Journal of Neuroscience Research|January 24, 2007
Apoptotic and behavioral sequelae of mild brain trauma in miceDavid Tweedie, Anat Milman, Harold W Holloway, et al.
Biochemical and Biophysical Research Communications|August 3, 2025
Monoterpenoid fluorophthalimide IMiDs that lack human cereblon binding: synthesis and anti-proliferative, anti-angiogenic and anti-inflammatory activitiesWeiming Luo, Kathleen M Garchitorena, David Tweedie, et al.
International Journal of Nanomedicine|November 27, 2025
Enhanced Bioavailability of a Thionated IMiD Derivative Nanosuspension for Parkinson's Disease Targeting α-SynucleinLuca Casula, Maria Francesca Palmas, Maria Cristina Cardia, et al.
Pharmacogenetics and Genomics|March 13, 2008
Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's diseaseRoger Lane, Howard H Feldman, Joanne Meyer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 18, 2014
Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryNigel H Greig, David Tweedie, Lital Rachmany, et al.
Scientific Reports|June 18, 2017
Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degenerationLital Rachmany, David Tweedie, Vardit Rubovitch, et al.
Pageof 34